# A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies

> **NCT05456893** · — · RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 95 (estimated)

## Conditions studied

- Ulcerative Colitis
- Inflammatory Bowel Diseases

## Interventions

- **PROCEDURE:** Procedure: endoscopic biopsy
- **PROCEDURE:** Blood sampling
- **PROCEDURE:** stool sampling

## Key facts

- **NCT ID:** NCT05456893
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-28
- **Primary completion:** 2027-09-09
- **Final completion:** 2027-09-09
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05456893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05456893, "A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05456893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*